435
Participants
Start Date
September 13, 2017
Primary Completion Date
June 15, 2022
Study Completion Date
June 24, 2022
Panitumumab
6 mg/kg iv over 60 minutes, day 1
Irinotecan
150 mg/sqm iv over 60 minutes day 1
Oxaliplatin
85 mg/sqm iv over 2 hours day 1
l-leucovorin
200 mg/sqm iv over 2 hours
5-fluorouracil
400 mg/sqm iv bolus, day 1 followed by 2400 mg/sqm 48 h-continuous infusion, starting on day 1;
Fondazione IRCCS Istituto Nazionale Tumori, Milan
Fondazione IRCCS Istituto Oncologico Veneto, Padua
Azienda Ospedaliera Universitaria Integrata Verona, Verona
A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica, Pisa
Gruppo Oncologico del Nord-Ovest
OTHER